| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Andreas Greinacher | Q64337422 |
| P2093 | author name string | Hannes Wandt | |
| Kerstin Schäfer-Eckart | |||
| P2860 | cites work | Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation | Q24197779 |
| Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders | Q24201018 | ||
| Why has demand for platelet components increased? A review | Q28249969 | ||
| The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia | Q28305486 | ||
| Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 | Q29615429 | ||
| Dose of prophylactic platelet transfusions and prevention of hemorrhage | Q30496886 | ||
| Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology | Q33336231 | ||
| Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions | Q33340587 | ||
| Guidelines for the use of platelet transfusions | Q33348675 | ||
| Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion | Q33349375 | ||
| The quantitative relation between platelet count and hemorrhage in patients with acute leukemia | Q33353564 | ||
| Relationship between platelet count and bleeding risk in thrombocytopenic patients | Q33361658 | ||
| Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients | Q33364823 | ||
| Elective coronary stent implantation in a patient with unstable angina and thrombocytopenia. | Q33367137 | ||
| A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation | Q33369834 | ||
| Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia | Q33371869 | ||
| Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses | Q33372452 | ||
| Thrombocytopenia and cancer | Q33384149 | ||
| Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia | Q33395035 | ||
| Idiopathic thrombocytopenic purpura and coronary artery disease: comparison between coronary artery bypass grafting and percutaneous coronary intervention | Q33395339 | ||
| The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia | Q33400714 | ||
| Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study | Q33402744 | ||
| Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. | Q33403000 | ||
| A no-prophylaxis platelet-transfusion strategy for hematologic cancers | Q33407550 | ||
| Immune thrombocytopenia patients requiring anticoagulation--maneuvering between Scylla and Charybdis. | Q33407659 | ||
| Platelet transfusions and bleeding complications associated with plasma exchange catheter placement in patients with presumed thrombotic thrombocytopenic purpura | Q33408077 | ||
| Haematological cancer: Prophylactic platelet transfusion is frequently not necessary | Q33408843 | ||
| Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies | Q33409577 | ||
| Platelet transfusions for critically ill patients with thrombocytopenia | Q33412094 | ||
| Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products | Q33414951 | ||
| The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Q33501152 | ||
| Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia | Q33502337 | ||
| Platelet transfusions: Impact on hemostasis, thrombosis, inflammation and clinical outcomes | Q34708937 | ||
| Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update | Q34719264 | ||
| Anticoagulation in the treatment of established venous thromboembolism in patients with cancer | Q37593823 | ||
| Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? | Q37671038 | ||
| Blood component transfusion in critically ill patients. | Q38118517 | ||
| Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines | Q38292751 | ||
| Recommendations for platelet transfusion by the Joint Thrombocyte Working Party of the German Societies of Transfusion Medicine and Immunohaematology (DGTI), Thrombosis and Haemostasis Research (GTH), and Haematology and Oncology (DGHO) | Q44501462 | ||
| Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial. | Q51742200 | ||
| The bleeding risk index | Q63446621 | ||
| A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia | Q77363637 | ||
| Platelets--to transfuse or not to transfuse | Q84760512 | ||
| Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH | Q87016000 | ||
| Donor exposures in recipients of pooled platelet concentrates | Q95800290 | ||
| P433 | issue | 48 | |
| P921 | main subject | platelet transfusion | Q23925170 |
| P304 | page(s) | 809-815 | |
| P577 | publication date | 2014-11-01 | |
| P1433 | published in | Deutsches Ärzteblatt international | Q27722165 |
| P1476 | title | Platelet transfusion in hematology, oncology and surgery | |
| P478 | volume | 111 |
| Q98893935 | Alteration of smoking habit at time of first diagnosis influences survival of patients with HNSCC |
| Q89639168 | Effects of Platelet Rich Fibrin on Full Thickness Skin Grafts in the Rat Model-Planimetry Results |
| Q42976401 | Exemption: Promyelocytic Leukemia |
| Q94384204 | In Reply |
| Q91714481 | Platelet Pathogen Reduction Technologies Alter the MicroRNA Profile of Platelet-Derived Microparticles |
| Q42976398 | Platelet Transfusion and Hemorrhage. |
| Q47409875 | Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours |
Search more.